Two-year efficacy and safety update from JAVELIN Merkel 200 Part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy Meeting Abstract
| Authors: | Sandhu, S.; Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; Linette, G. P.; Milella, M.; Hennessy, M.; Bajars, M.; Hicking, C.; D'Angelo, S. P. |
| Abstract Title: | Two-year efficacy and safety update from JAVELIN Merkel 200 Part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy |
| Meeting Title: | Medical Oncology Group of Australia Incorporated Annual Scientific Meeting: New Directions in Personalised Cancer Therapy |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 14 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2018 Aug 1-3 |
| Meeting Location: | Adelaide, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2018-08-01 |
| Start Page: | 52 |
| End Page: | 53 |
| Language: | English |
| ACCESSION: | WOS:000439493100015 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.13021 |
| Notes: | Meeting Abstract -- Source: Wos |
